CAR T cells ignite antitumor immunity.

Area of Science:

• Immunology
• Oncology
• Cancer Immunotherapy

Background:

• Broadening immune responses via antigen spreading is a critical challenge in cancer immunotherapy.
• Chimeric antigen receptor (CAR)-T cell therapy has shown promise but faces challenges with antigenically heterogeneous tumors.

Purpose of the Study:

• To investigate whether vaccine boosting of CAR-T cells can enhance endogenous immunity and promote antigen spread.
• To determine the mechanism by which boosted CAR-T cells eliminate antigenically diverse solid tumors.

Main Methods:

• Chimeric antigen receptor (CAR)-T cells were administered to mice with solid tumors.
• Vaccine boosting was employed to enhance the immune response.
• Interferon-gamma (IFNγ) levels and antigen spread were analyzed.

Main Results:

• Vaccine boosting of CAR-T cells in mice significantly promoted endogenous immune responses.
• This approach led to antigen spread, enabling the elimination of antigenically heterogeneous solid tumors.
• The mechanism of tumor elimination was critically dependent on interferon-gamma (IFNγ).

Conclusions:

• Vaccine boosting of CAR-T cells is a viable strategy to broaden immune responses in cancer therapy.
• Antigen spread, mediated by IFNγ, is crucial for eliminating diverse solid tumors using this approach.
• This study offers a promising mechanism for improving the efficacy of CAR-T cell therapy against complex cancers.